TRIPS Agreement

TRIPS Agreement
Name	Agreement on Trade-Related Aspects of Intellectual Property Rights
Type	Multilateral treaty
Date signed	15 April 1994
Location signed	Marrakesh, Morocco
Date effective	1 January 1995
Condition effective	Ratification by WTO members
Signatories	All World Trade Organization members
Languages	English, French, Spanish
Wikisource	Agreement on Trade-Related Aspects of Intellectual Property Rights

TRIPS Agreement. The Agreement on Trade-Related Aspects of Intellectual Property Rights is a foundational multilateral treaty administered by the World Trade Organization. It establishes minimum standards for the regulation of various forms of intellectual property by national governments, directly linking trade and IP law. Its implementation has profoundly influenced global innovation, public health, and development policies.

Background and history

The push for a global intellectual property framework gained momentum during the Uruguay Round of negotiations under the General Agreement on Tariffs and Trade. Led by major economies like the United States, the European Union, and Japan, proponents argued that disparate national laws created trade distortions. Key industry groups, including the Pharmaceutical Research and Manufacturers of America and the Motion Picture Association of America, lobbied vigorously for strong protections. The final text was concluded as part of the Marrakesh Agreement which established the World Trade Organization, marking a significant shift from WIPO-administered conventions to a system with enforceable dispute settlement.

Key provisions and requirements

The treaty mandates WTO members to adhere to core principles of national treatment and most-favored-nation treatment. It sets minimum standards for protecting copyrights, trademarks, geographical indications, industrial designs, patents, and undisclosed information. For pharmaceuticals and agrochemicals, it requires a minimum twenty-year patent term. It also obligates countries to establish enforcement procedures within their domestic legal systems, including customs measures to intercept counterfeit goods.

Impact on developing countries

Implementation posed significant challenges for developing nations like India, Brazil, and South Africa. The requirement to grant product patents for medicines disrupted local generic drug industries, raising concerns about access to essential medicines. The World Bank and UNCTAD published studies highlighting potential impacts on technology transfer and public health budgets. In response, countries utilized transition periods and, following the Doha Declaration, provisions for compulsory licensing to address national emergencies like the HIV/AIDS pandemic.

Dispute settlement and enforcement

Compliance is overseen through the WTO Dispute Settlement Understanding, a binding mechanism. Notable cases include disputes between the United States and India over pharmaceutical patent protection, and between the European Union and Canada concerning patent term restoration. The Dispute Settlement Body can authorize trade sanctions for non-compliance, giving the agreement significant legal force compared to earlier WIPO treaties. This system has been invoked in conflicts involving agricultural chemicals and entertainment media.

Criticism and controversies

The agreement has faced sustained criticism from NGOs such as Médecins Sans Frontières and Oxfam, which argue it prioritizes corporate profits over human rights like health. Academics like Joseph Stiglitz and Ha-Joon Chang have criticized its restrictive impact on development. Major controversies include the high cost of antiretroviral drugs in Sub-Saharan Africa and the protection of biotechnological inventions affecting farmers' rights to save seeds, as seen in disputes involving Monsanto.

Amendments and subsequent agreements

The first formal amendment to the treaty, the Protocol Amending the TRIPS Agreement, was adopted to implement the 2001 Doha Declaration on public health, easing rules for exporting medicines under compulsory license. Subsequent multilateral agreements, like the Anti-Counterfeiting Trade Agreement and CPTPP, have sought to establish "TRIPS-plus" standards. Ongoing negotiations in forums like the WIPO and the World Health Organization continue to address issues of access, biodiversity, and traditional knowledge.

Category:World Trade Organization agreements Category:Intellectual property law Category:1994 treaties